- Home
- CORT vs IDCC Comparison
CORT vs IDCC Comparison
Compare CORT & IDCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- IDCC
- Stock Information
- Founded
- CORT 1998
- IDCC 1972
- Country
- CORT United States
- IDCC United States
- Employees
- CORT N/A
- IDCC N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- IDCC Multi-Sector Companies
- Sector
- CORT Health Care
- IDCC Miscellaneous
- Exchange
- CORT Nasdaq
- IDCC Nasdaq
- Market Cap
- CORT 7.5B
- IDCC 6.9B
- IPO Year
- CORT N/A
- IDCC N/A
- Fundamental
- Price
- CORT $71.76
- IDCC $269.87
- Analyst Decision
- CORT Strong Buy
- IDCC Strong Buy
- Analyst Count
- CORT 4
- IDCC 1
- Target Price
- CORT $138.25
- IDCC $160.00
- AVG Volume (30 Days)
- CORT 864.0K
- IDCC 288.4K
- Earning Date
- CORT 07-31-2025
- IDCC 07-31-2025
- Dividend Yield
- CORT N/A
- IDCC 0.89%
- EPS Growth
- CORT N/A
- IDCC 43.26
- EPS
- CORT 1.11
- IDCC 14.28
- Revenue
- CORT $716,080,000.00
- IDCC $892,584,000.00
- Revenue This Year
- CORT $35.85
- IDCC N/A
- Revenue Next Year
- CORT $35.22
- IDCC N/A
- P/E Ratio
- CORT $64.39
- IDCC $18.88
- Revenue Growth
- CORT 25.71
- IDCC 21.83
- 52 Week Low
- CORT $33.34
- IDCC $129.76
- 52 Week High
- CORT $117.33
- IDCC $277.95
- Technical
- Relative Strength Index (RSI)
- CORT 52.18
- IDCC 67.03
- Support Level
- CORT $70.75
- IDCC $266.87
- Resistance Level
- CORT $74.54
- IDCC $276.88
- Average True Range (ATR)
- CORT 2.74
- IDCC 9.77
- MACD
- CORT 0.26
- IDCC 0.69
- Stochastic Oscillator
- CORT 73.13
- IDCC 83.32
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About IDCC InterDigital Inc.
InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.